LRRK2 and Parkinson disease: Additionally, loss-of-function mutations of PINK or Parkin, or a gain-of-function mutation of LRRK2, led to resistance of the Miro1 isoform to proteasomal degradation and delayed mitophagy (87), implicating impaired mitophagy as a unifying mechanism for these PD-causing mutations.